Stemirna Therapeutics
RNA technology based drug development company designed to maximize the potential of RNA science.
Launch date
Employees
Market cap
-
Enterprise valuation
€750m (Public information from May 2023)
Shanghai Shanghai (HQ)
Authorizing premium user...